# Study of DS-8201a for Participants With Advanced Solid Malignant Tumors

> **NCT03383692** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Neoplasm Metastasis

## Interventions

- **DRUG:** DS-8201a
- **DRUG:** Ritonavir
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT03383692
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-12
- **Primary completion:** 2018-09-26
- **Final completion:** 2023-09-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03383692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03383692, "Study of DS-8201a for Participants With Advanced Solid Malignant Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03383692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*